These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 2499960)
21. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen. Austen DE; Smith JK Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994 [TBL] [Abstract][Full Text] [Related]
22. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process. Mason EC; Pepper DS; Griffin B Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742 [TBL] [Abstract][Full Text] [Related]
23. Polyvinylpyrrolidone (PVP): a new precipitating agent for human and bovine factor VIII and fibrinogen. Casillas G; Simonetti C Br J Haematol; 1982 Apr; 50(4):665-72. PubMed ID: 6802165 [TBL] [Abstract][Full Text] [Related]
24. [A new human factor VIII concentrate. Preparation and clinical use]. Simonetti C; Casillas G; FarÃas C; De los Santos JC Medicina (B Aires); 1981; 41 Suppl():249-52. PubMed ID: 6808288 [No Abstract] [Full Text] [Related]
25. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate. Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661 [TBL] [Abstract][Full Text] [Related]
26. Factor VIII collection by pheresis. McLeod BC; Sassetti RJ; Cole ER; Pierce MI Lancet; 1980 Sep; 2(8196):671-3. PubMed ID: 6106786 [TBL] [Abstract][Full Text] [Related]
27. An improved thaw-siphon method for the cryoprecipitate preparation. Kang EP Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544 [TBL] [Abstract][Full Text] [Related]
28. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates. Farrugia A; Douglas S; James J; Whyte G; Herrington R Thromb Haemost; 1990 Nov; 64(3):374-8. PubMed ID: 2128967 [TBL] [Abstract][Full Text] [Related]
29. Preparation of factor VIII concentrates by cryoprecipitate sedimentation. Boudart DJ; Naud MF Transfusion; 1979; 19(5):594-6. PubMed ID: 505533 [TBL] [Abstract][Full Text] [Related]
30. A factor VIII concentrate of intermediate purity and higher potency. Smith JK; Evans DR; Stone V; Snape TJ Transfusion; 1979; 19(3):299-306. PubMed ID: 36691 [TBL] [Abstract][Full Text] [Related]
31. Fractionation of individual, biologically active factor VIII multimers. Perret BA; Furlan M; Kneubuehl F; Beck EA Biochim Biophys Acta; 1981 Jun; 669(1):98-104. PubMed ID: 6794637 [TBL] [Abstract][Full Text] [Related]
32. [Isolation and some properties of factor VIII (antihemophilic factor)]. Bykowska K; Lopaciuk S; Michalski R Acta Haematol Pol; 1976 OCT-DEC; 7(4):283-92. PubMed ID: 998139 [TBL] [Abstract][Full Text] [Related]
33. Preparation of cryoprecipitated factor VIII concentrates. Slichter SJ; Counts RB; Henderson R; Harker LA Transfusion; 1976; 16(6):616-26. PubMed ID: 996922 [TBL] [Abstract][Full Text] [Related]
34. Factor VIII concentrate prepared from blood donors stimulated by intranasal administration of a vasopressin analogue. Mikaelsson M; Nilsson IM; Vilhardt H; Wiechel B Transfusion; 1982; 22(3):229-33. PubMed ID: 6806950 [TBL] [Abstract][Full Text] [Related]
35. Strategy for purification of coagulation factor concentrates. Clark DB; Drohan WN; Miekka SI; Katz AJ Ann Clin Lab Sci; 1989; 19(3):196-207. PubMed ID: 2658728 [TBL] [Abstract][Full Text] [Related]